Pnc Financial Services Group, Inc. Clovis Oncology, Inc. Transaction History

Pnc Financial Services Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$1.43 - $3.14 $3,843 - $8,440	-2,688 Reduced 92.28%	225 $0
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $7,257 - $12,794	2,688 Added 1194.67%	2,913 $7,000
Q3 2021 Nov 05, 2021	SELL	$4.06 - $5.8 $23,446 - $33,495	-5,775 Reduced 96.25%	225 $1,000
Q1 2021 May 07, 2021	SELL	$4.81 - $10.34 $4,810 - $10,340	-1,000 Reduced 14.29%	6,000 $42,000
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $8,260 - $12,820	2,000 Added 40.0%	7,000 $33,000
Q3 2019 Nov 08, 2019	BUY	$3.93 - $15.35 $11,790 - $46,050	3,000 Added 150.0%	5,000 $19,000
Q4 2018 Feb 08, 2019	SELL	$11.63 - $32.67 $25,818 - $72,527	-2,220 Reduced 52.61%	2,000 $35,000
Q3 2018 Nov 09, 2018	SELL	$29.37 - $49.48 $95,834 - $161,453	-3,263 Reduced 43.61%	4,220 $0
Q2 2018 Aug 10, 2018	BUY	$42.06 - $62.4 $86,475 - $128,294	2,056 Added 37.88%	7,483 $0
Q1 2018 May 11, 2018	SELL	$50.12 - $67.72 $2.45 Million - $3.31 Million	-48,871 Reduced 90.01%	5,427 $0
Q4 2017 Feb 09, 2018	BUY	$57.69 - $84.58 $2.9 Million - $4.25 Million	50,238 Added 1237.39%	54,298 $0
Q3 2017 Nov 13, 2017	BUY	$67.17 - $84.81 $272,710 - $344,328	4,060	4,060 $0

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.